FDA grants accelerated approval for first plasmid DNA-based immunotherapy for adults
The U.S. Food and Drug Administration granted accelerated approval for Voceryq to treat adults with recurrent respiratory papillomatosis.
Topic
FDA
Vitality Works recalls 365 Whole Foods ashwagandha capsules over potential Salmonella
Vitality Works Inc. recalled one lot of 365 Whole Foods Market ashwagandha capsules due to potential Salmonella contamination.